Plott Ronald Todd

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

4
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Phio Pharmaceuticals Corp.—Open-market buy$5,2005,000 sharesSep 30, 2026Phio Pharmaceuticals Corp.$5,200Buy · Sep 30Open-market buy5,000Sep 30, 2026
Phio Pharmaceuticals Corp.—Open-market buy$5,1505,000 sharesSep 30, 2026Phio Pharmaceuticals Corp.$5,150Buy · Sep 30Open-market buy5,000Sep 30, 2026
Phio Pharmaceuticals Corp.—Awardnothing paid17,000 sharesSep 29, 2026Phio Pharmaceuticals Corp.nothing paidAward · Sep 29Award17,000Sep 29, 2026
Phio Pharmaceuticals Corp.—Open-market buy$17,10015,000 sharesAug 20, 2026Phio Pharmaceuticals Corp.$17,100Buy · Aug 20Open-market buy15,000Aug 20, 2026